Pacific Biosciences Of California (PACB) Current Assets (2010 - 2026)

Pacific Biosciences Of California's Current Assets history runs 17 years deep, the most recent figure standing at $369.5 million for Q1 2026.

• In Q1 2026, Current Assets fell 16.95% year-over-year to $369.5 million; the TTM figure through Mar 2026 stood at $369.5 million (down 16.95% YoY), while the FY2025 annual figure was $375.1 million, down 24.34% from the prior year.
• Current Assets was $369.5 million for Q1 2026 at Pacific Biosciences Of California, down from $375.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.0 billion in Q1 2022 to a low of $369.5 million in Q1 2026.
• Historically, Current Assets has averaged $687.6 million across 5 years, with a median of $677.0 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Current Assets retreated 3.46% in 2023, then slumped 34.28% in 2025.
• A 5-year view of Current Assets shows it stood at $852.1 million in 2022, then fell by 12.91% to $742.0 million in 2023, then tumbled by 33.2% to $495.7 million in 2024, then slipped by 24.34% to $375.1 million in 2025, then declined by 1.48% to $369.5 million in 2026.
• The last three Current Assets figures came in at $369.5 million (Q1 2026), $375.1 million (Q4 2025), and $394.2 million (Q3 2025), per Business Quant data.